|
Fiscal Period: June
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
48 102 | 64 502 | 68 373 | 89 914 | 97 314 | 93 148 | - | - |
Enterprise Value (EV)2 |
51 227 | 68 074 | 72 378 | 94 712 | 101 308 | 100 632 | 104 148 | 103 826 |
P/E ratio |
36,1x | 37,4x | 35,7x | 42,9x | 41,0x | 39,8x | 33,2x | 28,3x |
Yield |
1,28% | 1,21% | 1,23% | 1,02% | 1,04% | 1,08% | 1,26% | 1,47% |
Capitalization / Revenue |
6,95x | 8,15x | 8,01x | 9,83x | 9,44x | 8,68x | 6,78x | 6,17x |
EV / Revenue |
7,40x | 8,60x | 8,48x | 10,4x | 9,83x | 9,37x | 7,58x | 6,88x |
EV / EBITDA |
25,0x | 25,4x | 25,1x | 30,2x | 27,2x | 28,6x | 22,0x | 19,0x |
Price to Book |
15,2x | 15,8x | 13,0x | 13,8x | 11,6x | 7,05x | 6,09x | 5,33x |
Nbr of stocks (in thousands) |
453 434 | 452 400 | 453 139 | 454 049 | 455 126 | 481 735 | - | - |
Reference price (USD) |
106 | 143 | 151 | 198 | 214 | 193 | 193 | 193 |
Announcement Date |
08/15/2017 | 08/14/2018 | 08/13/2019 | 08/18/2020 | 08/17/2021 | - | - | - |
1 AUD in Million 2 USD in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: June
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
6 923 | 7 915 | 8 539 | 9 151 | 10 310 | 10 734 | 13 741 | 15 100 |
EBITDA1 |
2 048 | 2 677 | 2 879 | 3 136 | 3 720 | 3 517 | 4 731 | 5 474 |
Operating profit (EBIT)1 |
1 769 | 2 380 | 2 504 | 2 717 | 3 130 | 2 959 | 3 913 | 4 563 |
Operating Margin |
25,6% | 30,1% | 29,3% | 29,7% | 30,4% | 27,6% | 28,5% | 30,2% |
Pre-Tax Profit (EBT)1 |
1 690 | 2 281 | 2 341 | 2 573 | 2 963 | 2 798 | 3 540 | 4 163 |
Net income1 |
1 337 | 1 729 | 1 919 | 2 103 | 2 375 | 2 273 | 2 807 | 3 285 |
Net margin |
19,3% | 21,8% | 22,5% | 23,0% | 23,0% | 21,2% | 20,4% | 21,8% |
EPS2 |
2,94 | 3,81 | 4,23 | 4,62 | 5,21 | 4,86 | 5,82 | 6,82 |
Dividend per Share2 |
1,36 | 1,72 | 1,85 | 2,02 | 2,22 | 2,08 | 2,44 | 2,84 |
Announcement Date |
08/15/2017 | 08/14/2018 | 08/13/2019 | 08/18/2020 | 08/17/2021 | - | - | - |
1 USD in Million 2 USD |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: June
|
2018 S1 |
2018 S2 |
2019 S1 |
2019 S2 |
2020 S1 |
2020 S2 |
2021 S1 |
2021 S2 |
2022 S1 |
2022 S2 |
Net sales1 |
4 147 | 3 768 | 4 505 | 4 034 | 4 911 | 4 240 | 5 739 | 4 571 | 6 041 | 4 787 |
EBITDA1 |
1 617 | 1 060 | 1 719 | 1 160 | 1 836 | 1 300 | 2 638 | 1 081 | 2 479 | 1 079 |
Operating profit (EBIT)1 |
1 476 | 904 | 1 553 | 951 | 1 632 | 1 085 | 2 358 | 772 | 2 215 | 839 |
Operating Margin |
35,6% | 24,0% | 34,5% | 23,6% | 33,2% | 25,6% | 41,1% | 16,9% | 36,7% | 17,5% |
Pre-Tax Profit (EBT)1 |
- | 857 | 1 460 | 881 | 1 561 | 1 011 | 2 251 | 712 | 2 145 | 620 |
Net income1 |
1 086 | 643 | 1 161 | 758 | 1 248 | 855 | 1 810 | 565 | 1 760 | 517 |
Net margin |
26,2% | 17,1% | 25,8% | 18,8% | 25,4% | 20,2% | 31,5% | 12,4% | 29,1% | 10,8% |
EPS2 |
2,40 | 1,41 | 2,56 | 1,67 | 2,74 | 1,88 | 3,98 | 1,23 | 3,85 | 1,17 |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - |
Announcement Date |
02/13/2018 | 08/14/2018 | 02/12/2019 | 08/13/2019 | 02/11/2020 | 08/18/2020 | 02/17/2021 | 08/17/2021 | 02/15/2022 | - |
1 USD in Million 2 USD |
|
|
|
Fiscal Period: June
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
3 126 | 3 572 | 4 005 | 4 798 | 3 993 | 7 484 | 11 000 | 10 678 |
Net Cash position1 |
- | - | - | - | - | - | - | - |
Leverage (Debt / EBITDA) |
1,53x | 1,33x | 1,39x | 1,53x | 1,07x | 2,13x | 2,33x | 1,95x |
Free Cash Flow1 |
558 | 1 123 | 527 | 1 282 | 2 426 | 1 410 | 1 552 | 2 564 |
ROE (Net Profit / Equities) |
46,7% | 47,7% | 41,1% | 35,7% | 31,9% | 19,1% | 18,8% | 19,4% |
Shareholders' equity1 |
2 866 | 3 622 | 4 666 | 5 889 | 7 454 | 11 873 | 14 918 | 16 906 |
ROA (Net Profit / Asset) |
16,0% | 17,4% | 16,6% | 15,1% | 14,1% | 9,21% | 9,33% | 9,91% |
Assets1 |
8 343 | 9 949 | 11 544 | 13 890 | 16 886 | 24 667 | 30 085 | 33 134 |
Book Value Per Share2 |
6,98 | 9,02 | 11,6 | 14,4 | 18,4 | 27,4 | 31,8 | 36,3 |
Cash Flow per Share2 |
2,74 | 4,19 | 3,62 | 5,46 | 7,94 | 5,25 | 5,45 | 7,56 |
Capex1 |
689 | 779 | 1 118 | 1 207 | 1 196 | 1 396 | 1 578 | 1 665 |
Capex / Sales |
9,95% | 9,84% | 13,1% | 13,2% | 11,6% | 13,0% | 11,5% | 11,0% |
Announcement Date |
08/15/2017 | 08/14/2018 | 08/13/2019 | 08/18/2020 | 08/17/2021 | - | - | - |
1 USD in Million 2 USD |
|
| |
|
|
KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health |
Capitalization (AUD) |
132 558 916 761 |
Capitalization (USD) |
93 147 998 567 |
Net sales (USD) |
10 310 000 000 |
Number of employees |
25 000 |
Sales / Employee (USD) |
412 400 |
Free-Float |
95,0% |
Free-Float capitalization (AUD) |
125 929 913 369 |
Free-Float capitalization (USD) |
88 489 855 505 |
Avg. Exchange 20 sessions (USD) |
233 352 415 |
Average Daily Capital Traded |
0,18% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|